Le Kremlin-Bicetre

• Phase 3 Study of ALXN1850 in Pediatric Participants with HPP Previously Treated with Asfotase Alfa Revoked
  2023-505674-15-00 5 Hypophosphatasia
• ABTECT-1 – ABX464 Treatment Evaluation for ulcerative Colitis Therapy -1 Not authorised
  2022-500535-36-00 5 Moderately to severely active ulcerative colitis
• ABTECT-Maintenance – ABX464 Treatment Evaluation for ulcerative Colitis Therapy Not authorised
  2022-500537-84-00 5 Moderately to severely active ulcerative colitis
• TIC-TAC-SAM « Comparison of two strategies of etoposide initiation in severe sporadic hemophagocytic lymphohistiocytosis in intensive care: … Not authorised
  2024-511807-41-00 5 Hemophagocytic lymphohistiocytosis (HLH)
• A clinical study of MK-7240 for the treatment of ulcerative colitis (MK-7240-001) Unknown
  2025-523766-25-00 5 Ulcerative colitis
• Echec-MAT - A combination of antibiotics to improve neonatal mortality and morbidity for pregnancies complicated with previable labour and i … Pending
  2023-505500-37-00 5 Pregnant women with singleton pregnancies hospitalized for threatened
• Efficacy and safety of zoledronate versus placebo on pain at week 12 in pediatric patients with chronic recurrent multifocal osteomyelitis r … Pending
  2023-506420-93-00 4 Chronic recurrent multifocal osteomyelitis (CRMO)
• Effect of Sildenafil in association to Hypothermia on survival without brain lesions In term Neonates with hypoxic-ischemic Encephalopathy: … Pending
  2023-508928-35-00 10 Hypoxic ischemic encephalopathy
• SYMBOL CLINICAL : Treatment of severe ocular chemical burns by subconjunctival injection of allogeneic mesenchymal stem cells: a multicentre … Pending
  2023-509713-37-00 4 Patient with severe eye chemical burns
• SEMAFORCRANIO : Multicenter, double-blind, parallel, randomized controlled trial of the efficacy of semaglutide in hypothalamic obesity seco … Pending
  2024-511114-20-00 5 Craniopharyngioma
• TIC-TAC-SAM « Comparison of two strategies of etoposide initiation in severe sporadic hemophagocytic lymphohistiocytosis in intensive care: … Pending
  2024-511807-41-01 5 Hemophagocytic lymphohistiocytosis (HLH)
• CANDISHORT : A randomized study of a short duration therapy for candidemia Pending
  2024-514244-81-00 5 Uncomplicated candidemia
• TociCCAre - Clinical trial evaluating tocilizumab for the treatment of chondrocalcinosis Pending
  2024-515956-19-00 5 Chondrocalcinosis
• Rituximab therapy in anti-MAG patients with characteristics of good responders: THERAMAG study Pending
  2024-516335-27-00 5 anti-MAG neuropathy
• Bosentan in the treatment of Giant Cell Arteritis Pending
  2024-517030-17-00 4 Newly diagnosed or relapsing Giant-cell arteritis
• An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH). Pending
  2024-520218-23-00 10 Pulmonary Arterial Hypertension
• Comparison of two prophylactic antibiotic regimens in case of preterm prelabor rupture of membranes before 34 weeks of gestation: a randomiz … Pending
  2025-520842-31-00 5 Population of study participants Pregnant women with PPROM at 22 to 33
• MAINRITSys : Rituximab vs placebo for maintenance in systemic sclerosis – interstitial lung disease Pending
  2025-521331-36-00 10 Patient with stabilized SSc-ILD (as defined by a decline of FVC ≤ 5%)
• PALETTE - Trial for personalisation of sepsis treatment in children and adults Pending
  2025-521371-31-00 4 Sepsis
• ANAKINRA IN THE TREATMENT OF PEDIATRIC ACUTE MYOCARDITIS Pending
  2025-521478-32-00 5 PEDIATRIC ACUTE MYOCARDITIS
• Evaluation of the efficacy of corticosteroids in septic arthritis in adults: Randomized double-blind controlled trial [CORSAR] Pending
  2025-522193-37-00 5 Septic arthritis
• LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2 Pending
  2025-522475-28-00 5 Pulmonary Hypertension (PH) with Heart Failure with preserved left ven
• Intermediate versus standard dose enoxaparin to prevent venous thromboembolism in severe trauma patients: a multicenter double blind randomi … Pending
  2025-522832-16-00 10 Severe trauma
• A study of pelabresib and ruxolitinib compared to placebo and ruxolitinib in adult patients with myelofibrosis who have not received prior t … Pending
  2025-523555-66-00 5 Myelofibrosis

Showing 1–24 of 177 trials